AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

